Roger Kravtzoff

Title: Roger Kravtzoff: Innovator in Interferon-beta Compositions

Introduction

Roger Kravtzoff is a notable inventor based in Algans, France. He has made significant contributions to the field of biotechnology, particularly in the development of interferon-beta compositions. His innovative work has led to the creation of a patent that addresses important therapeutic applications.

Latest Patents

Roger Kravtzoff holds a patent for "IFN-beta compositions, preparation methods and uses thereof." This invention pertains to interferon-beta (IFN-beta) compositions that include a grafted poly(glutamic acid) polymer. The polymer has an average molecular weight between 26,000 and 40,000 g/mol and is grafted with alpha-tocopherol substituents. The average molar grafting ratio is between 4.5-5.5 moles %, and the weight/weight ratio between the grafted polymer and IFN-beta ranges from 24 to 125. The invention also covers the preparation methods of these compositions and their application in creating therapeutic compositions that deliver IFN-beta over an extended period.

Career Highlights

Roger Kravtzoff is associated with Ares Trading S.A., where he continues to work on innovative solutions in biotechnology. His expertise in the field has allowed him to develop groundbreaking compositions that have the potential to improve therapeutic outcomes for patients.

Collaborations

Roger has collaborated with notable colleagues such as Daniel Leblanc and Evert Nicolaas Lamme. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Roger Kravtzoff is a distinguished inventor whose work in interferon-beta compositions showcases his commitment to advancing biotechnology. His innovative patent reflects his expertise and dedication to improving therapeutic applications.